Ryan Specialty (NYSE:RYAN) Stock Price Target Raised at Mizuho

Key Points

• Mizuho raised its price target on Ryan Specialty from $40 to $48 but maintained a neutral rating; the new target implies just 0.57% upside from the prior close.
• Analysts have a consensus Hold rating and an average price target of $52.62, with eight Buy, ten Hold, and one Sell recommendation.
• Ryan Specialty reported quarterly EPS of $0.51, beating the $0.49 estimate, while revenue of $789.96 million came in below analyst expectations of $792.99 million.

Ryan Specialty (NYSE:RYAN - Get Free Report) had its target price hoisted by stock analysts at Mizuho from $40.00 to $48.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has a "neutral" rating on the stock. Mizuho's price target points to a potential upside of 0.57% from the company's previous close.

RYAN has been the topic of a number of other research reports. Piper Sandler reduced their target price on Ryan Specialty from $48.00 to $40.00 and set a "neutral" rating on the stock in a report on Tuesday, October 6th. Royal Bank Of Canada lowered their price target on Ryan Specialty from $55.00 to $52.00 and set an "outperform" rating for the company in a report on Friday, October 30th. Barclays boosted their price target on Ryan Specialty from $46.00 to $48.00 and gave the stock an "overweight" rating in a report on Friday, July 31st. Weiss Ratings upgraded Ryan Specialty from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, September 18th. Finally, UBS Group reduced their price objective on Ryan Specialty from $55.00 to $52.00 and set a "buy" rating on the stock in a research note on Monday, November 2nd. Eight equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $52.62.

Ryan Specialty Price Performance

Shares of NYSE:RYAN traded up $1.58 during midday trading on Friday, hitting $47.73. The stock had a trading volume of 428,522 shares, compared to its average volume of 2,196,539. The company's 50-day moving average price is $41.08 and its 200-day moving average price is $39.00. The company has a market capitalization of $12.01 billion, a P/E ratio of 58.92, a price-to-earnings-growth ratio of 0.99 and a beta of 0.54. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 4.03. Ryan Specialty has a fifty-two week low of $29.28 and a fifty-two week high of $58.91.

Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its quarterly earnings results on Thursday, October 29th. The company reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.49 by $0.02. The business had revenue of $789.96 million for the quarter, compared to analyst estimates of $792.99 million. Ryan Specialty had a net margin of 8.25% and a return on equity of 47.77%. During the same quarter last year, the business posted $0.47 EPS. As a group, equities research analysts predict that Ryan Specialty will post 2.18 EPS for the current fiscal year.

Insiders Place Their Bets

In other Ryan Specialty news, CEO Benjamin Wuller sold 50,000 shares of the business's stock in a transaction on Monday, November 9th. The shares were sold at an average price of $47.31, for a total transaction of $2,365,500.00. Following the sale, the chief executive officer owned 94,095 shares of the company's stock, valued at approximately $4,451,634.45. The trade was a 34.70% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 52.03% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of RYAN. Vulcan Value Partners LLC grew its position in Ryan Specialty by 20.0% during the 2nd quarter. Vulcan Value Partners LLC now owns 7,912,669 shares of the company's stock worth $298,782,000 after acquiring an additional 1,317,334 shares during the last quarter. Bank of America Corp DE raised its position in Ryan Specialty by 34.8% in the first quarter. Bank of America Corp DE now owns 1,508,083 shares of the company's stock valued at $50,883,000 after purchasing an additional 389,505 shares during the last quarter. Fenimore Asset Management Inc boosted its stake in shares of Ryan Specialty by 1.8% during the third quarter. Fenimore Asset Management Inc now owns 1,330,600 shares of the company's stock valued at $49,232,000 after purchasing an additional 23,994 shares in the last quarter. Guardian Point Capital LP boosted its stake in shares of Ryan Specialty by 15.0% during the first quarter. Guardian Point Capital LP now owns 575,000 shares of the company's stock valued at $19,400,000 after purchasing an additional 75,000 shares in the last quarter. Finally, Renaissance Technologies LLC boosted its stake in shares of Ryan Specialty by 1,374.2% during the first quarter. Renaissance Technologies LLC now owns 536,600 shares of the company's stock valued at $18,105,000 after purchasing an additional 500,200 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors.

About Ryan Specialty

Ryan Specialty is a specialty insurance organization that provides distribution, underwriting and related services to insurance brokers, agents and carriers. Its business includes wholesale brokerage, which helps insurance professionals place coverage for risks that may be difficult to insure in the standard market, and underwriting management services for specialty insurance products. The company works across a range of property and casualty insurance lines, including professional liability, transportation, property, casualty and other specialty risks.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.